BRIEF published on 12/27/2024 at 07:05, 25 days ago Relief Therapeutics fait le point sur une éventuelle fusion avec Renexxion Partenariat Stratégique Produits Biopharmaceutiques THÉRAPEUTIQUE DE SECOURS Fusion Renexxion Thérapies Gastro-intestinales
BRIEF published on 12/27/2024 at 07:05, 25 days ago Relief Therapeutics Updates on Potential Merger with Renexxion Strategic Partnership Biopharmaceuticals Relief Therapeutics Renexxion Merger Gastrointestinal Therapies
PRESS RELEASE published on 12/27/2024 at 07:00, 25 days ago Relief Therapeutics Provides Update on Potential Transaction with Renexxion Relief Therapeutics provides update on potential reverse merger with Renexxion, focusing on enhancing shareholder value and future growth opportunities in gastrointestinal disorders therapies Merger Biopharmaceutical Relief Therapeutics Clinical-stage Renexxion
BRIEF published on 12/16/2024 at 07:05, 1 month 5 days ago Relief Therapeutics annonce des résultats prometteurs de l'essai GOLIKE sur la PKU Biopharmaceutique Essai Clinique PKU GOLIKE Phénylcétonurie Contrôle Métabolique
BRIEF published on 12/16/2024 at 07:05, 1 month 5 days ago Relief Therapeutics Reports Promising Outcomes from PKU GOLIKE Trial Biopharmaceutical Clinical Trial PKU GOLIKE Phenylketonuria Metabolic Control
PRESS RELEASE published on 12/16/2024 at 07:00, 1 month 5 days ago Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial Relief Therapeutics announces final readout of PKU GOLIKE clinical trial showing superior metabolic control during prolonged fasting in PKU patients. Results aim to promote awareness and adoption of PKU GOLIKE Clinical Trial Relief Therapeutics PKU GOLIKE Phenylketonuria Metabolic Control
BRIEF published on 12/13/2024 at 23:05, 1 month 7 days ago Relief Therapeutics va mettre fin à ses obligations de déclaration auprès de la SEC avec le dépôt du formulaire 15F OTCQB Bourse Suisse SIX THÉRAPEUTIQUE DE SECOURS Formulaire 15F Rapports De La SEC
BRIEF published on 12/13/2024 at 23:05, 1 month 7 days ago Relief Therapeutics to End SEC Reporting Obligations with Form 15F Filing OTCQB SIX Swiss Exchange Relief Therapeutics SEC Reporting Form 15F
PRESS RELEASE published on 12/13/2024 at 23:00, 1 month 7 days ago Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations Relief Therapeutics announces filing of Form 15F to terminate SEC reporting obligations, maintaining listing on SIX Swiss Exchange and U.S. over-the-counter market SIX Swiss Exchange Relief Therapeutics SEC Reporting Form 15F U.S. OTCQB
BRIEF published on 11/11/2024 at 07:05, 2 months 10 days ago Relief Therapeutics Reports Positive Outcomes in RLF-TD011 Trial for Epidermolysis Bullosa Relief Therapeutics RLF-TD011 Clinical Trial Results Epidermolysis Bullosa Microbiome Diversity
Published on 01/20/2025 at 20:30, 10 hours 35 minutes ago TaxBandits PRO Features Empower Tax Professionals To Streamline 1099, W-2, 94x, and ACA Filings for the 2024 Tax Year
Published on 01/20/2025 at 20:30, 10 hours 35 minutes ago Taranis Acquires 100% Interest in 1,634 Ha Property Adjoining Thor
Published on 01/20/2025 at 19:00, 12 hours 5 minutes ago Polaris Renewable Energy Announces Q4 and Annual 2024 Financial Results Release Date and Investor Call Details
Published on 01/20/2025 at 16:10, 14 hours 55 minutes ago Game-Changing Partnership Set to Disrupt Inman Event
Published on 01/20/2025 at 14:30, 16 hours 35 minutes ago Wolfden Sells Timberland Parcel for $2.1 Million in Non-Dilutive Financing
Published on 01/21/2025 at 06:58, 7 minutes ago DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter
Published on 01/21/2025 at 06:29, 35 minutes ago Avolta debuts in Tunisia with new contract for fifteen duty-free stores across five airports
Published on 01/21/2025 at 04:59, 2 hours 5 minutes ago Alibaba Cloud Announced the Latest AI Models, Tools and Infrastructure Available to Drive More Efficient Global AI Community
Published on 01/20/2025 at 20:56, 10 hours 9 minutes ago Artnet: Annual General Meeting 2024 on February 27, 2025, Expanded Supervisory Board and New, Strong Supervisory Board Candidates
Published on 01/21/2025 at 07:00, 5 minutes ago Biophytis et AskHelpU signent un accord de co-développement dans les maladies rares neuromusculaires en Chine
Published on 01/21/2025 at 07:00, 5 minutes ago Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China
Published on 01/20/2025 at 18:49, 12 hours 16 minutes ago Reporting on share buyback transactions carried out between January 13 and January 16, 2025
Published on 01/20/2025 at 18:49, 12 hours 16 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 13 et le 16 janvier 2025
Published on 01/20/2025 at 18:27, 12 hours 38 minutes ago Déclaration des transactions sur actions propres réalisées du 13 au 17 janvier 2025
